Skip to main content
Clinical Trials/ISRCTN90201732
ISRCTN90201732
Completed
Phase 2

Does Laryngeal Reinnervation or Type I Thyroplasty give better voice results for patients with Unilateral Vocal Fold Paralysis (VOCALIST): a feasibility study

niversity College London Hospitals NHS Foundation Trust0 sites30 target enrollmentDecember 16, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Topic: Ear, Nose and Throat
Sponsor
niversity College London Hospitals NHS Foundation Trust
Enrollment
30
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2017 protocol in https://pubmed.ncbi.nlm.nih.gov/28965097/ (added 30/11/2020)

Registry
who.int
Start Date
December 16, 2015
End Date
May 1, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. UVFP due to unilateral recurrent laryngeal nerve paralysis of traumatic, iatrogenic or idiopathic origin of between 6 and 60 months duration. Or symptoms that have not sufficiently improved with speech therapy alone, as determined by the patient and agreed by a multidisciplinary clinical team, after 6 months and pending a surgical decision.
  • 2\. Age from 18 to 70 years old.
  • 3\. Male or female
  • 4\. Able to provide informed consent
  • 5\. A significant voice disorder as measured by perceptual rating (Grade \=2 GRBAS Scale) and Voice Handicap Index (VHI\-10 score \>16\)
  • 6\. Common laryngeal electromyography (EMG, neurophysiological) criteria (Koufman Grades 2\-5\) in either the thyroarytenoid (TA) or posterior cricoarytenoid (PCA) muscle on the paralysed side
  • Original inclusion criteria 1\-2:
  • 1\. UVFP due to unilateral recurrent laryngeal nerve paralysis of traumatic, iatrogenic or idiopathic origin
  • of between 6 and 36 months duration; or symptoms that have not sufficiently improved with speech therapy alone, as determined by the patient and agreed by a multidisciplinary clinical team, after 6 months and pending a surgical decision
  • 2\. Aged between 18 and 60

Exclusion Criteria

  • 1\. Impaired vocal fold mobility but a normal EMG (Koufman Grade I)
  • 2\. Severe lung disorders
  • 3\. Structural vocal fold lesions such as polyp
  • 4\. Previous laryngeal framework surgery
  • 5\. Cricoarytenoid joint fixation (CAJF)
  • 6\. Significant non\-laryngeal speech abnormality (severe dysarthria determined by a panel of trained speech therapists)
  • 7\. Previous Level 2,3 or 4 thyroid neck dissection
  • 8\. Previous ipsilateral surgical neck dissection
  • 9\. Previous radiotherapy to the head and neck
  • 10\. Laryngeal injection of a rapidly absorbable material in the last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials